Jinneng Technology has announced that its molybdenum metal products, such as molybdenum powder and targets, are not directly used in semiconductor memory chips. While molybdenum targets are applied in display screen production, their revenue contribution is less than 1%, and the company has no products currently used in semiconductor memory chips, addressing recent market rumors about molybdenum replacing tungsten. Separately, a subsidiary of Xinnuowei received approval for clinical trials of its folate receptor ADC, SYS6041, for ovarian cancer treatment. AI
IMPACT Clarifies market speculation regarding material applications, with no direct impact on AI development or deployment.
RANK_REASON The item is a clarification of market rumors and a report on a clinical trial approval, not a primary release of new technology or a significant industry event.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →